Business Context and Reporting Period
Company: The Clorox Company
Filing Type: Form 8-K (Current Report)
Date of Report: November 14, 2011
Event: Execution of an underwriting agreement for a registered public offering of senior notes.
Key Financial Metrics
- Debt Issuance: $300 million aggregate principal amount of 3.80% senior notes due 2021.
- Expected Annual Expense: Approximately 5.13% of the aggregate principal amount. This figure includes underwriting commissions, estimated offering expenses, discounts, and losses associated with certain hedges executed in connection with the sale.
- Closing Date: Expected November 17, 2011, subject to customary closing conditions.
- Revenue/Profit/Cash Flow: The filing text does not provide a clear value for revenue, profit, cash flow, or operating margins as this is a transaction-specific report.
Material Changes
This filing represents a material change in the Company's capital structure through the incurrence of new long-term debt. The Company has committed to issuing $300 million in senior notes, which will increase total debt obligations and result in the specified annual expense burden.
Outlook, Risks, and Contingencies
- Transaction Status: The offering is expected to close on November 17, 2011, contingent upon customary closing conditions.
- Cost Structure: Management notes that the effective cost of capital for this issuance is higher than the coupon rate (3.80%) due to the inclusion of underwriting fees and hedge losses, resulting in an estimated 5.13% annual expense.
- Legal Documentation: The transaction involves a Third Supplemental Indenture with Wells Fargo Bank, National Association, as trustee.
Investor Verification Checklist
- Verify the final closing of the $300 million offering on or around November 17, 2011.
- Confirm the actual net proceeds received after deducting underwriting commissions and offering expenses.
- Review the specific terms of the hedges executed to understand the source of the losses contributing to the 5.13% expense rate.
- Monitor future 10-Q or 10-K filings for the impact of this new debt on the Company's leverage ratios and interest coverage.